跳至主要内容
临床试验/EUCTR2014-001978-33-GB
EUCTR2014-001978-33-GB进行中(未招募)1 期

How can we optimise inhaled beta2 agonist dose as 'reliever' medicine for wheezy pre-school children? - Optimising salbutamol dose for wheezy preschool children

Brighton and Sussex University Hospitals NHS Trust0 个研究点目标入组 156 人开始时间: 2014年5月20日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
156

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - Age 2 years 6 months to 6 years 11 months
  • - Recurrent wheeze, defined as at least 3 episodes of wheeze over the previous 12 months by the parent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 155
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • - Other major airway or lung disease, e.g. chronic lung disease of prematurity, cystic fibrosis, and abnormal airway anatomy.
  • - Long acting beta-2 agonists within 1 week of the study visit
  • - Recent (within 2 weeks) treatment with systemic corticosteroids or leukotriene inhibitors.
  • - Involved in a drug study within the last 30 days

研究者

发起方
Brighton and Sussex University Hospitals NHS Trust

相似试验